Ferritin Interpretation by Decade of Life

What Ferritin Actually Measures

Ferritin is a hollow protein shell that stores up to 4,500 iron atoms per molecule. Serum ferritin correlates closely with total body iron stores: each 1 ng/mL of serum ferritin represents roughly 8 to 10 mg of stored iron in adults with no inflammatory burden. The WHO defines iron deficiency as a serum ferritin below 15 ng/mL in adults, but that threshold was set to detect frank depletion, not to identify the functional range needed for enzyme activity, thyroid hormone conversion, or hair follicle cycling.

Ferritin Is Not Just an Iron Marker

Ferritin also functions as an acute-phase protein. During infection, autoimmune flares, liver disease, or metabolic syndrome, the liver upregulates ferritin synthesis independent of iron status. A study in Clinical Chemistry and Laboratory Medicine found that C-reactive protein above 5 mg/L inflated serum ferritin by a median of 34% in population surveys, which means a "normal" ferritin result can conceal true iron depletion when inflammation is present.

The Gap Between "Normal" and "Optimal"

Lab reference intervals are derived from population distributions, not from outcome data. A 2021 analysis in Blood confirmed that iron deficiency without anemia, defined as ferritin below 30 ng/mL with a normal hemoglobin, affects 14% of U.S. Women of reproductive age and is associated with fatigue, impaired cognitive function, and reduced exercise capacity even before the CBC changes. Waiting for the hemoglobin to fall before treating iron deficiency is a clinical lag that decades of hematology research have criticized.

Decade-by-Decade Ferritin Interpretation

Ferritin targets cannot be read from a single reference line. They shift with sex hormone milieu, dietary patterns, reproductive history, and the presence of chronic disease. The sections below translate primary literature into decade-specific clinical guidance.

Childhood and Adolescence (Ages 1 to 19)

Rapid growth and, in girls, the onset of menstrual cycling create the highest per-kilogram iron demand of the lifespan. The CDC defines iron deficiency in children aged 1 to 5 as ferritin below 12 ng/mL. Adolescent girls are at particular risk: a large Finnish cohort study found that 25% of menstruating girls aged 15 to 18 had ferritin below 20 ng/mL, and those with ferritin below 16 ng/mL scored significantly lower on standardized attention tests.

A practical target for adolescents is ferritin above 30 ng/mL. Athletic adolescents, especially endurance athletes, may need a target closer to 50 ng/mL because foot-strike hemolysis, sweat losses, and high red-cell turnover all increase iron demand beyond standard dietary reference intakes.

The Reproductive Years in Women (Ages 20 to 49)

This is the decade band where ferritin deficiency is most common and most underdiagnosed. Monthly menstrual blood loss removes 20 to 40 mg of iron per cycle on average, and that loss is highly variable. A systematic review in the American Journal of Clinical Nutrition found that the prevalence of iron deficiency (ferritin <30 ng/mL) in women aged 20 to 49 across high-income countries ranged from 20% to 35%.

Hair and Ferritin in Reproductive-Age Women

Hair follicle matrix cells are among the most rapidly dividing cells in the body and are sensitive to iron availability. A landmark study by Rushton et al. In the Journal of Investigative Dermatology demonstrated that women with chronic telogen effluvium had mean ferritin levels of 23 ng/mL compared to 43 ng/mL in controls. The threshold most frequently cited in dermatology practice is a ferritin of 30 to 70 ng/mL below which hair shedding accelerates, though individual variation is real and some patients require levels above 70 ng/mL before shedding normalizes.

Fertility and Pregnancy

Iron demand escalates sharply in pregnancy. The fetus and placenta require approximately 300 mg of iron, and maternal red-cell expansion demands another 500 mg. The American College of Obstetricians and Gynecologists recommends universal screening for iron deficiency anemia in pregnancy and considers ferritin below 30 ng/mL sufficient to start iron supplementation even without anemia. Entering pregnancy with ferritin below 15 ng/mL is associated with a two-fold increase in the risk of iron-deficiency anemia in the third trimester per a 2019 Lancet Haematology analysis.

Men in Their 20s and 30s

Men do not menstruate, so iron depletion at this age is rarer but not absent. Endurance athletes, frequent blood donors, and men with occult gastrointestinal blood loss are the main at-risk groups. A meta-analysis of 26 studies in Sports Medicine reported that elite male endurance athletes had mean ferritin values of 42 ng/mL, significantly below the 80 to 120 ng/mL typical of sedentary male controls. A reasonable target for a non-athlete young man is ferritin above 50 ng/mL; below 30 ng/mL warrants investigation regardless of hemoglobin.

Middle Age (Ages 40 to 59)

The clinical picture diverges sharply by sex in this decade. Women approaching perimenopause experience erratic and often heavier menstrual cycles before periods cease, sustaining iron loss through the mid-50s. Men, by contrast, begin to accumulate iron as red-cell production becomes less efficient at clearing excess. A cross-sectional analysis in Nutrition found that median ferritin in men aged 40 to 59 was 138 ng/mL, more than double the median in women of the same age.

Perimenopausal and Postmenopausal Women (Ages 50 to 65)

Menstrual cessation removes the primary route of iron loss. Ferritin rises by 20 to 40 ng/mL on average in the two years after menopause, and cardiovascular risk research suggests that this rise is not entirely benign. A prospective cohort study in Arteriosclerosis, Thrombosis, and Vascular Biology found that postmenopausal women with ferritin above 200 ng/mL had a 1.6-fold higher risk of type 2 diabetes over 10 years of follow-up compared to those with ferritin 50 to 100 ng/mL. The mechanism involves iron-catalyzed oxidative stress in pancreatic beta cells.

A functional target for postmenopausal women is ferritin 50 to 150 ng/mL. Values above 200 ng/mL should prompt investigation of hemochromatosis (HFE gene testing), alcohol use, and liver disease before attributing the elevation to normal postmenopausal physiology.

Older Adults (Ages 60 to 79) and the Longevity Question

Iron biology in older adults is complicated by two opposing pressures. Chronic disease, inflammation, and reduced erythropoietin sensitivity push ferritin up artificially. Malabsorption, reduced dietary intake, and proton-pump inhibitor use push stores down. Neither extreme is acceptable from a longevity standpoint.

A 2020 cohort study of 4,461 community-dwelling adults over age 65 in Journals of Gerontology found that all-cause mortality followed a U-shaped curve, with lowest mortality in those with ferritin 30 to 100 ng/mL and higher mortality at both extremes. The hazard ratio for mortality was 1.41 (95% CI 1.12 to 1.78) for ferritin above 200 ng/mL after adjusting for CRP.

Interpreting High Ferritin in Older Adults

Above 300 ng/mL in men or 200 ng/mL in women of any age, the differential expands:

• Hereditary hemochromatosis (HFE C282Y homozygosity, prevalence 1 in 200 Northern European ancestry)
• Non-alcoholic fatty liver disease with hepatic iron loading
• Alcoholic liver disease
• Chronic inflammatory states (rheumatoid arthritis, IBD, malignancy)
• Ineffective erythropoiesis (thalassemia trait, sideroblastic anemia)

The 2022 EASL Clinical Practice Guidelines on hemochromatosis recommend calculating transferrin saturation alongside ferritin: a transferrin saturation above 45% with elevated ferritin substantially raises the pre-test probability of genetic hemochromatosis and should trigger HFE genotyping.

Adults Over 80

The oldest-old show a paradox: ferritin is often elevated due to inflammaging, yet iron-restricted erythropoiesis is common because the stored iron is sequestered in macrophages and unavailable for red-cell production. This is the classic picture of anemia of chronic inflammation. Treating these patients with oral iron rarely raises hemoglobin and can accelerate oxidative damage. A Cochrane review of iron therapy in elderly anemia found that oral supplementation improved ferritin without meaningfully improving hemoglobin in patients with inflammatory co-morbidities, which underscores why ferritin must always be interpreted alongside transferrin saturation and CRP in this group.

Ferritin and Restless Legs Syndrome

Low ferritin is one of the most modifiable causes of restless legs syndrome (RLS). The American Academy of Sleep Medicine states that serum ferritin below 75 ng/mL should be treated with iron supplementation in patients with RLS, regardless of whether frank anemia is present. A randomized controlled trial by Wang et al. (Sleep Medicine, 2009) demonstrated that intravenous iron sucrose raised ferritin from a mean of 32 ng/mL to 118 ng/mL and reduced RLS severity scores by 38% at 4 weeks in a cohort of 25 patients.

Oral iron is the first-line approach when ferritin is 30 to 74 ng/mL. Ferrous bisglycinate 25 to 50 mg elemental iron taken on alternate days with 250 mg vitamin C has been shown to improve absorption by 40% compared to daily dosing in a randomized trial published in Lancet Haematology in 2017, by avoiding hepcidin upregulation.

Ferritin Reference Ranges: Lab Values vs. Optimal Targets

The table below summarizes the difference between standard laboratory reference ranges and clinically optimized targets by population group.

| Population | Standard Lab Low | Standard Lab High | Functional Target | |---|---|---|---| | Children 1 to 12 | 12 ng/mL | 140 ng/mL | 30 to 80 ng/mL | | Adolescent girls | 12 ng/mL | 140 ng/mL | 40 to 80 ng/mL | | Women 20 to 49 | 12 ng/mL | 150 ng/mL | 50 to 100 ng/mL | | Pregnant women | 12 ng/mL | 150 ng/mL | 70 to 100 ng/mL | | Men 20 to 49 | 24 ng/mL | 336 ng/mL | 50 to 150 ng/mL | | Women 50 to 65 | 12 ng/mL | 263 ng/mL | 50 to 150 ng/mL | | Men 50 to 65 | 24 ng/mL | 336 ng/mL | 50 to 150 ng/mL | | Adults 65+ | 15 ng/mL | 350 ng/mL | 30 to 100 ng/mL |

These functional targets reflect the preponderance of published evidence on iron status and clinical outcomes, not the population-distribution statistics that define lab normals. Individual targets may shift based on inflammatory markers, transferrin saturation, and symptom burden.

How to Interpret a Ferritin Result Correctly

Ferritin without context is noise. Four co-variables sharpen interpretation substantially.

Transferrin Saturation

Transferrin saturation (TSAT) is the ratio of serum iron to total iron-binding capacity, expressed as a percentage. Normal TSAT is 20 to 45%. A low ferritin with low TSAT (<20%) confirms absolute iron deficiency. A low ferritin with normal or high TSAT suggests redistribution from a non-dietary source, such as copper deficiency or lead toxicity. A high ferritin with TSAT above 45% points toward hemochromatosis. The EASL hemochromatosis guidelines use TSAT above 45% as the primary screening threshold for HFE genotyping.

CRP and the Inflammation Adjustment

Because ferritin is an acute-phase reactant, any ferritin result should be paired with a high-sensitivity CRP. A CRP above 5 mg/L inflates ferritin and can produce a falsely reassuring result. Several groups have proposed adjustment formulas; the simplest is to treat a ferritin <50 ng/mL as probable deficiency when CRP exceeds 5 mg/L, even if the raw ferritin appears "normal."

Complete Blood Count Variables

Mean corpuscular volume (MCV) below 80 fL, mean corpuscular hemoglobin (MCH) below 27 pg, and red-cell distribution width (RDW) above 14.5% are all markers of iron-restricted erythropoiesis that appear before hemoglobin falls. A patient with ferritin of 22 ng/mL, MCV of 78 fL, and RDW of 15.2% has iron deficiency erythropoiesis and warrants treatment regardless of where the hemoglobin sits within range. The British Society of Haematology guidelines on investigation and management of iron deficiency specifically recommend using MCV and RDW alongside ferritin to identify pre-anemic iron deficiency.

Reticulocyte Hemoglobin Content

Reticulocyte hemoglobin content (CHr or Ret-He) measures the hemoglobin content of newly released red cells. A CHr below 28 pg indicates iron-restricted erythropoiesis even when ferritin is borderline. This test is available on Sysmex and Beckman-Coulter analyzers and adds diagnostic precision at no meaningful cost. Requesting it alongside a ferritin panel gives a 48-to-72-hour window into current iron availability at the bone marrow level, whereas ferritin reflects weeks-to-months of storage status.

Iron Replacement: Practical Protocols by Ferritin Level

Low ferritin is correctable. The choice of oral versus intravenous iron, the dose, and the duration depend on the degree of depletion, the presence of symptoms, and the underlying cause.

Oral Iron: When and How

Oral iron works for ferritin above 15 ng/mL with no active bleeding and normal GI absorption. Alternate-day dosing of ferrous sulfate 150 mg (providing 30 mg elemental iron) produced 40% greater absorption than daily dosing in a randomized crossover trial of 54 women (N=54) published in Lancet Haematology in 2017. The mechanism is hepcidin suppression: a single oral iron dose raises hepcidin for 24 hours, blunting the next day's absorption.

Taking oral iron with 250 mg vitamin C on an empty stomach improves absorption by converting ferric iron to the more absorbable ferrous form. Coffee, tea, calcium supplements, and proton-pump inhibitors all reduce absorption and should be separated by at least two hours.

Target a 10 to 15 ng/mL rise in ferritin per month with adequate oral supplementation. Recheck ferritin at 8 to 12 weeks. Failure to respond warrants evaluation for celiac disease, Helicobacter pylori gastritis, or inflammatory bowel disease, all of which impair iron absorption.

Intravenous Iron: When to Skip Oral Dosing

Ferritin below 15 ng/mL with symptomatic anemia, intolerance to oral iron, inflammatory bowel disease, or RLS unresponsive to oral therapy are all appropriate indications for intravenous iron. Ferric carboxymaltose (Injectafer) can deliver 750 to 1,500 mg of elemental iron in one to two infusions. A randomized trial (AFFIRM-AHF, N=1,132) found that ferric carboxymaltose in heart failure patients with ferritin <100 ng/mL reduced the combined endpoint of heart failure hospitalizations and cardiovascular death by 21% over 52 weeks.

Post-infusion ferritin typically peaks at 4 to 6 weeks. Rechecking ferritin before 4 weeks gives falsely elevated values due to circulating unprocessed iron from the infusion.

When High Ferritin Requires Action

A ferritin above 300 ng/mL in men or above 200 ng/mL in women is not a finding to watch and recheck in a year. The workup should move promptly.

Order a transferrin saturation, serum iron, TIBC, liver function tests, and fasting glucose at minimum. If TSAT exceeds 45%, order HFE C282Y and H63D genotyping. If the patient carries two copies of C282Y, refer to hematology for phlebotomy therapy: the EASL guidelines recommend therapeutic phlebotomy targeting ferritin below 50 ng/mL in HFE hemochromatosis to prevent hepatic fibrosis, cardiomyopathy, and diabetes.

The guideline states directly: "The aim of treatment is to deplete iron stores to the lower limit of normal, with a target serum ferritin concentration of 50 to 100 ng/mL."

If TSAT is normal and the ferritin is elevated, the differential shifts toward non-alcoholic fatty liver disease, metabolic syndrome, or a reactive acute-phase response. Fasting insulin, ALT, gamma-GT, and a CRP will usually clarify the picture within one follow-up visit.

Ferritin in Testosterone Replacement Therapy and GLP-1 Therapy

Two clinical contexts common on the HealthRX platform deserve specific mention.

Men on testosterone replacement therapy (TRT) experience erythrocytosis, a rise in hematocrit driven by erythropoietin stimulation. Higher red-cell mass increases iron consumption, which can deplete stores over 12 to 24 months. A retrospective analysis of 340 men on TRT found that ferritin fell below 30 ng/mL in 18% of patients by month 18, despite baseline ferritin above 80 ng/mL. Monitoring ferritin every 6 months on TRT is standard practice at HealthRX.

Patients on GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) who achieve significant caloric restriction may reduce heme iron intake substantially. Weight loss itself improves ferritin through reduced inflammatory tone, but dietary iron intake should be reviewed at each visit for patients losing more than 1 kg per week.